| Tretinoin | Approved Investigational Nutraceutical | ATP10D | 57205 |
upregulated | Tretinoin results in increased expression of ATP10D mRNA | 4p12 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP11A | 23250 |
downregulated | Tretinoin results in decreased expression of ATP11A mRNA | 13q34 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP13A3 | 79572 |
downregulated | Tretinoin results in decreased expression of ATP13A3 mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP1A2 | 477 |
downregulated | Tretinoin results in decreased expression of ATP1A2 mRNA | 1q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP1A3 | 478 |
downregulated | Tretinoin results in decreased expression of ATP1A3 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP23 | 91419 |
downregulated | Tretinoin results in decreased expression of ATP23 mRNA | 12q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP23 | 91419 |
upregulated | Tretinoin results in increased expression of ATP23 mRNA | 12q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP2A2 | 488 |
downregulated | Tretinoin results in decreased expression of ATP2A2 mRNA | 12q24.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP2A3 | 489 |
downregulated | Tretinoin results in decreased expression of ATP2A3 mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP2B1 | 490 |
downregulated | Tretinoin results in decreased expression of ATP2B1 mRNA | 12q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP5G2 | 517 |
downregulated | Tretinoin results in decreased expression of ATP5G2 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6AP1 | 537 |
upregulated | Tretinoin results in increased expression of ATP6AP1 mRNA | Xq28 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V0A1 | 535 |
upregulated | Tretinoin results in increased expression of ATP6V0A1 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V0A2 | 23545 |
downregulated | Tretinoin results in decreased expression of ATP6V0A2 mRNA | 12q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V0D1 | 9114 |
upregulated | Tretinoin results in increased expression of ATP6V0D1 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V0E2-AS1 | 401431 |
upregulated | Tretinoin results in increased expression of ATP6V0E2-AS1 mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V1A | 523 |
downregulated | Tretinoin results in decreased expression of ATP6V1A mRNA | 3q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V1A | 523 |
upregulated | Tretinoin results in increased expression of ATP6V1A mRNA | 3q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V1B1 | 525 |
downregulated | Tretinoin results in decreased expression of ATP6V1B1 mRNA | 2p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP6V1G1 | 9550 |
upregulated | Tretinoin results in increased expression of ATP6V1G1 mRNA | 9q32 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP7A | 538 |
upregulated | Tretinoin results in increased expression of ATP7A mRNA | Xq21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ATP8B1 | 5205 |
upregulated | Tretinoin results in increased expression of ATP8B1 mRNA | 18q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ATRNL1 | 26033 |
upregulated | Tretinoin results in increased expression of ATRNL1 mRNA | 10q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ATRX | 546 |
downregulated | Tretinoin results in decreased expression of ATRX mRNA | Xq21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ATRX | 546 |
upregulated | Tretinoin results in increased expression of ATRX mRNA | Xq21.1 | |